# BioRegenx, Inc. (BRGX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BRGX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 426.2K | $ -26.4K | $ 26.6K | $ 2.17M | $ -4.53M |
| 2025 | $ 1.90M | $ -1.58M | $ 30.6K | $ 2.21M | $ -4.54M |
| 2024 | $ 2.53M | $ -21.66M | $ 38.49M | $ 2.16M | $ -3.38M |
| 2023 | $ 24.1K | $ -617.6K | $ 50.9K | $ 225.4K | $ -222.0K |
| 2022 | $ 47.1K | $ -87.5K | $ -72.2K | $ 241.0K | $ -201.5K |
| 2021 | $ 236.0K | $ -115.1K | $ -142.1K | $ 200.0K | $ -84.2K |
| 2020 | $ 515.2K | $ -351.4K | $ -119.9K | $ 150.0K | $ 177.6K |
| 2012 | $ 11.57M | $ -2.51M | $ 0 | $ 0 | $ -1.65M |
| 2005 | $ 1.6K | $ -50.0K | $ -13.3K | $ 69.0K | $ 41.5K |
| 2004 | $ 0 | $ -339.6K | $ -76.6K | $ 25.0K | $ 75.0K |
| 2003 | $ 0 | $ -686.5K | $ -179 | $ 35.0K | $ -153.4K |
| 2002 | $ 0 | $ -448.1K | $ -13.3K | $ 35.0K | $ -99.8K |
| 2001 | $ 0 | $ -274.6K | $ -39.7K | $ 35.0K | $ -61.2K |
| 2000 | $ 60.6K | $ -38.5K | $ -4.6K | $ 366.0K | $ 50.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.48 |
| Liabilities / Eq | -1.07 |
| Current Ratio | 0.05 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 0.57 |

## Other views

- [Metrics](https://sponda.capital/en/BRGX.md)
- [Charts](https://sponda.capital/en/BRGX/charts.md)
- [Compare](https://sponda.capital/en/BRGX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.